Pediatric Drug and Other Shortages
“In the age of supply chain shortages, it is imperative that the US pursue resilience and promote public policies to better protect the health of
Michael Posey
June 14, 2023
“In the age of supply chain shortages, it is imperative that the US pursue resilience and promote public policies to better protect the health of
The unprecedented ruling by a federal court in Texas that the FDA’s approval of the abortifacient drug mifepristone is analyzed in a Viewpoint article. The
FDA’s decision to permit the sale of over-the-counter hearing aids has the potential to create “a broader shift in the global hearing-aid market,” but only
FDA should consider differences in how tobacco products are marketed to and used by people of different biological sexes and gender identities as it develops
Based on an analysis of 170 FDA-approved drugs across 455 cancer indications from 2000 to 2022, researchers conclude that a “distinct ultra-orphan designation with greater
Newly approved prescription drugs with orphan drug designations were as lucrative over the first 5 years as agents approved for more common conditions, according to
Writing that “the basic nature of immune checkpoint inhibitor therapy poses questions,” authors of a Sounding Board article outline a path toward forcing innovation in
FDA yesterday took a number of important steps to simplify the use of the bivalent mRNA COVID-19 vaccines. The Moderna and Pfizer-BioNTech COVID-19 bivalent mRNA
The emerging SARS-CoV-2 subvariant XBB.1.16 may carry the previously rare symptom of conjunctivitis, according to a pediatrician in India and a news report in the
Children 6 months to 4 years of age are now eligible to receive a single booster dose of the Pfizer-BioNTech COVID-19 Vaccine, Bivalent, as a